367 related articles for article (PubMed ID: 21860465)
21. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
22. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
[TBL] [Abstract][Full Text] [Related]
23. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
Agudo R; Roiban GD; Reetz MT
Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
[TBL] [Abstract][Full Text] [Related]
24. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
[TBL] [Abstract][Full Text] [Related]
25. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
Cha GS; Ryu SH; Ahn T; Yun CH
Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
[TBL] [Abstract][Full Text] [Related]
26. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
27. P450 BM3-Catalyzed Regio- and Stereoselective Hydroxylation Aiming at the Synthesis of Phthalides and Isocoumarins.
Holec C; Hartrampf U; Neufeld K; Pietruszka J
Chembiochem; 2017 Apr; 18(7):676-684. PubMed ID: 28107587
[TBL] [Abstract][Full Text] [Related]
28. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity.
Roiban GD; Agudo R; Ilie A; Lonsdale R; Reetz MT
Chem Commun (Camb); 2014 Nov; 50(92):14310-3. PubMed ID: 25168091
[TBL] [Abstract][Full Text] [Related]
29. CYP106A2-A versatile biocatalyst with high potential for biotechnological production of selectively hydroxylated steroid and terpenoid compounds.
Schmitz D; Janocha S; Kiss FM; Bernhardt R
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):11-22. PubMed ID: 28780179
[TBL] [Abstract][Full Text] [Related]
30. Regioselectivity-driven evolution of CYP102D1 for improved synthesis of 3'-ortho-dihydroxyisoflavone.
Choi KY; Yang YH; Kim BG
Enzyme Microb Technol; 2015 Apr; 71():20-7. PubMed ID: 25765306
[TBL] [Abstract][Full Text] [Related]
31. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
[TBL] [Abstract][Full Text] [Related]
32. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
33. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
34. An efficient light-driven P450 BM3 biocatalyst.
Tran NH; Nguyen D; Dwaraknath S; Mahadevan S; Chavez G; Nguyen A; Dao T; Mullen S; Nguyen TA; Cheruzel LE
J Am Chem Soc; 2013 Oct; 135(39):14484-7. PubMed ID: 24040992
[TBL] [Abstract][Full Text] [Related]
35. Highly regioselective hydroxylation of polydatin, a resveratrol glucoside, for one-step synthesis of astringin, a piceatannol glucoside, by P450 BM3.
Le TK; Jang HH; Nguyen HT; Doan TT; Lee GY; Park KD; Ahn T; Joung YH; Kang HS; Yun CH
Enzyme Microb Technol; 2017 Feb; 97():34-42. PubMed ID: 28010771
[TBL] [Abstract][Full Text] [Related]
36. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
Lewis JC; Mantovani SM; Fu Y; Snow CD; Komor RS; Wong CH; Arnold FH
Chembiochem; 2010 Dec; 11(18):2502-5. PubMed ID: 21108271
[TBL] [Abstract][Full Text] [Related]
38. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
[TBL] [Abstract][Full Text] [Related]
39. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
40. P450
Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
